• Exchange: Copenhagen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Bavarian Nordic A/S

+ Add to Watchlist

BAVA:DC

97.0000 DKK 1.0000 1.04%

As of 03:55:32 ET on 04/16/2014.

Snapshot for Bavarian Nordic A/S (BAVA)

Open: 97.0000 Day's Range: 95.5000 - 98.0000 Volume: 23,026
Previous Close: 96.0000 52wk Range: 54.5000 - 110.0000 1-Yr Rtn: +39.57%

Stock Chart for BAVA

No chart data available.
  • BAVA:DC 96.5000
  • 1D
  • 1M
  • 1Y
96.0000
Interactive BAVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BAVA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 165.8120
Relative P/E vs. KFX -
Earnings Per Share (DKK) (ttm) -1.7904
Est. EPS (DKK) (12/2014) 0.5850
Est. PEG Ratio -
Market Cap (M DKK) 2,531.15
Shares Outstanding (M) 26.09
30 Day Average Volume 121,070
Price/Book (mrq) 2.5398
Price/Sale (ttm) 2.0875
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BAVA

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for BAVA

Bavarian Nordic A/S is a biotechnology company developing and producing vaccines for the treatment and prevention of cancer and infectious diseases. The company also manufactures and delivers modern smallpox vaccines for governments under national emergency rules.

Asger Joseph AamundChairmanGerard W M Van OdijkChairman
Anders HedegaardPresident/CEOJames B Breitmeyer "Jim"Pres:Cancer Vaccine/Exec VP
More Company Profile & Key Executives for BAVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil